NCT04925986 2025-04-17
Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC
Yale University
Phase 2 Terminated
Clinical Trials
4 trialsNCT03015740 2024-11-19
Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT04123704 2024-08-26
Sitravatinib in Metastatic Breast Cancer
Baylor Breast Care Center
Phase 2 Terminated
NCT02978859 2024-07-18
Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas
Columbia University
Phase 2 Completed